Cleared Special

K133862 - ACCU-CHEK AVIVA PLUS SYSTEM

K133862 is an FDA 510(k) clearance for ACCU-CHEK AVIVA PLUS SYSTEM, manufactured by Roche Diagnostics Corporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 131-day FDA review.

K133862 · Roche Diagnostics Corporation · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
131d
Days
Class 2
Risk

K133862 is an FDA 510(k) clearance for the ACCU-CHEK AVIVA PLUS SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Roche Diagnostics Corporation (Indianapolis, US). The FDA issued a Cleared decision on April 29, 2014 after a review of 131 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K133862

510(k) Number K133862 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2013
Decision Date April 29, 2014
Days to Decision 131 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 89d · This submission: 131d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K133862.
IDEAL LIFE GLUCO-MANAGER BLOOD GLUCOSE MONITORING SYSTEM
K132180 · Ideal Life, Inc. · Jun 2014
CONTOUR NEXT EZ BLOOD GLUCOSE METER
K130265 · Bayer Healthcare, LLC · Jun 2014
IHEALTH ALIGN MINI GLUCO-MONITORING SYSTEM
K133790 · Andon Health Co, Ltd. · May 2014
ELEMENTV BLOOD GLUCOSE MONITORING SYSTEM
K132406 · Infopia Co, Ltd. · Apr 2014
RIGHTEST DIABETES MANAGEMENT SOFTWARE AND ADAPTER (EXISTING CLEARED K113007),RIGHTEST NEW ADAPTERS-3,GE DIABETES MANAGEM
K133522 · Bionime Coporation · Apr 2014
EM40 SELF-MONITORING BLOOD GLUCOSE SYSTEM
K133389 · Eps Bio Technology Corp. · Apr 2014
K133862 · ACCU-CHEK AVIVA PLUS SYSTEM
Download PDF FDA Summary Roche Diagnostics Cor…